PharmaShots Weekly Snapshot (Sept 07 -11, 2020)
Published: Sept 10, 2020 | Tags: Janssen, Tremfya, Guselkumab, Biologic, US FDA, Selective, IL-23 inhibitor, Active Psoriatic Arthritis, Severe Plaque Psoriasis, human mAb
Published: Sept 10, 2020 | Tags: Janssen, Reports, sBLA, Submission, US, FDA, Darzalex Faspro, daratumumab, hyaluronidase-fihj, Treat, Patients, Light Chain, (AL), Amyloidosis
3. Chugai and Takeda Collaborate to Evaluate the Combination Therapy for Multiple Tumor Types in Japan
Published: Sept 10, 2020 | Tags: Chugai, Takeda, Collaborate, Evaluate, Combination Therapy, Multiple Tumor Types, Japan
4. GSK and Innoviva's Trelegy Ellipta (FF/UMEC/VI) Receive the US FDA's Approval for Asthma and COPD
Published: Sept 10, 2020 | Tags: GSK, Triple Therapy, Trelegy Ellipta, US FDA, Asthma, COPD, sNDA, Lung function, Acute Bronchospasm
Published: Sept 11, 2020 | Tags: Roche, Present, New Data, Ocrevus, (ocrelizumab), Relapsing-Remitting, Multiple Sclerosis, MSVirtual2020
6. Henlius Reports NMPA's Acceptance of NDA for HLX04 (biosimilar, bevacizumab)
Published: Sept 10, 2020 | Tags: Henlius , Reports, NMPA, Acceptance, NDA, HLX04, biosimilar, bevacizumab
Published: Sept 10, 2020 | Tags: Takeda, Reports, Results, Ninlaro, (ixazomib), P-III, Clinical Study, Newly Diagnosed, Multiple Myeloma
8. Jazz Collaborates with Redx Pharma to Develop Two Targeted Cancer Therapies
Published: Sept 09, 2020 | Tags: Jazz, Collaborates, Redx Pharma, Develop, Two, Targeted, Cancer Therapies
Published: Sept 10, 2020 | Tags: Genentech, Present, New Data, Enspryng, (satralizumab-mwge), for Neuromyelitis Optica Spectrum Disorder, MSVirtual2020
10. Pfizer and BioNTech to Supply 200M Doses of it COVID-19 Vaccine in the EU
Published: Sept 09, 2020 | Tags: Pfizer, BioNTech, Supply, 200M Doses, COVID-19 Vaccine, EU
Published: Sept 10, 2020 | Tags: AstraZeneca, Reports, Results, Fasenra, (benralizumab), P-III, OSTRO Study, Chronic Rhinosinusitis with Nasal Polyps
12. Bayer Collaborates with Recursion to Fortify Digital Drug Discovery for Fibrotic Diseases
Published: Sept 09, 2020 | Tags: Bayer, Collaborates, Recursion, Fortify, Digital Drug Discovery, Fibrotic Diseases
13. Sanofi to Present New Data of its Neurology Portfolio at MSVirtual2020
Published: Sept 10, 2020 | Tags: Sanofi, Present, New Data, Neurology Portfolio, MSVirtual2020
14. Regenxbio Reports First Patients Dosing in its P-II AAVIATE Study of RGX-314 for Wet AMD
Published: Sept 09, 2020 | Tags: Regenxbio, Reports, First Patients Dosing, P-II, AAVIATE Study, RGX-314, Wet AMD
Published: Sept 08, 2020 | Tags: Merck, Reports, Results, Gefapixant, (45mg), Two, P-III, Studies, Treatment, Refractory, or Unexplained, Chronic Cough
16. Theranica's Nerivio Wearable Device Receives CE Mark for Acute Treatment of Migraine in the Europe
Published: Sept 08, 2020 | Tags: Theranica, Nerivio, Wearable Device, CE mark, Acute Migraine, Chronic Migraine
17. Takeda Divests its Select Non-Core Assets in EU and Canada to Cheplapharm for $562M
Published: Sept 09, 2020 | Tags: Takeda, Divests, its Select Non-Core Assets, EU, Canada, Cheplapharm, $562M
Published: Sept 09, 2020 | Tags: Roche, Expands, MS Portfolio, Initiation, P-III, Clinical Program, Fenebrutinib, Ocrevus, (ocrelizumab)
Published: Sept 08, 2020 | Tags: Janssen, Imbruvica, (ibrutinib), Receives, EC, Marketing Authorization, Approval, Chronic Lymphocytic Leukaemia
20. Silence Therapeutics Highlights its R&D Pipeline and Initiates Dose Escalation Studies for SLN360
Published: Sept 08, 2020 | Tags: Silence Therapeutics, Highlights, Pipeline Portfolio, Provides, Research, Development, Update
Published: Sept 08, 2020 | Tags: Roche, cobas BKV Test, Receives, US, FDA, 510 (k) Clearance, Transplant Patients
22. Sanofi Reports Results of Dupixent (dupilumab) in P-III LIBERTY ASTHMA TRAVERSE OLE Study for Asthma
Published: Sept 07, 2020 | Tags: Sanofi, Reports, Results, Dupixent, dupilumab, P-III, LIBERTY ASTHMA TRAVERSE OLE, Study, for Asthma
23. Mylan to Acquire Aspen's Thrombosis Business in the EU for ~ $758M
Published: Sept 07, 2020 | Tags: Mylan, Acquire, Aspen, Thrombosis Business, EU, $758M
24. Boehringer Ingelheim and Pharmaxis Halt the Development of BI 1467335 for Diabetic Retinopathy
Published: Sept 08, 2020 | Tags: Boehringer Ingelheim, Pharmaxis, Halt, Development, BI 1467335, Diabetic Retinopathy
Published: Sept 06, 2020 | Tags: Project ALS, Prosetin, Receives, US, FDA, Orphan Drug Designation, Amyotrophic Lateral Sclerosis
27. Grifols to Acquire Remaining Stake of Alkahest for ~$146M
Published: Sept 06, 2020 | Tags: BMS, Acquire, Forbius, Adding, TGF-beta Inhibitor, Portfolio
Published: Sept 07, 2020 | Tags: AstraZeneca, Present, Results, Breztri Aerosphere, P-III, ETHOS Study, ERS, International Congress 2020
Published: Sept 07, 2020 | Tags: Genentech, Gavreto, (pralsetinib), Receives, US, FDA, Approval, Metastatic, Rearranged, During, Transfection, Fusion-Positive, Non-Small Cell Lung Cancer, Adults
Published: Sept 06, 2020 | Tags: Kite, Reports, sBLA, Submission, US, FDA for Yescarta, axicabtagene ciloleucel, Relapsed, Refractory, Indolent Non-Hodgkin Lymphomas
31. Chi-Med Initiates P-III FRESCO-2 Study of Fruquintinib in Metastatic Colorectal Cancer
Published: Sept 06, 2020 | Tags: Chi-Med, Initiates, P-III, FRESCO-2 Study, Fruquintinib, Metastatic Colorectal Cancer
Related News: PharmaShots Weekly Snapshot (Aug 31 Sept 04, 2020)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com